Scott RobertsonScott Robertson joined MPM’s BioVentures group in September 2006 from Merrill Lynch & Co., where he was an Associate in the Healthcare investment banking group. At Merrill, Scott performed comprehensive financial and strategic analyses and conducted extensive due diligence while completing a number of M&A and financing transactions for clients in the medical technology and biotechnology sectors. Prior to that, Scott was with Thomas Weisel Partners LLC, as an Analyst in their Healthcare investment banking group. He graduated from the University of Southern California, with a B.S. in Business Administration. |
|
